Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

ATV-1601

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 7, 2026 · PHASE 1 TRIAL

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

ClinicalTrials.gov

Phase 1 trial registration with no results reported; study is active but not yet recruiting, evaluating safety and dosing of a novel AKT1 inhibitor in advanced cancers.

PreliminaryNCT07038369 Breast Carcinoma ATV-1601

Reported

Planned enrollment134

Study phasePhase 1

Primary outcome: safety and toler…Approximately 48 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support